Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they're produced--a process called glycosylation.
https://news.google.com/__i/rss/rd/articles/CBMinwFodHRwczovL3RpbWVzb2ZpbmRpYS5pbmRpYXRpbWVzLmNvbS92aWRlb3MvbmV3cy9yZXNlYXJjaC1yZXZlYWxzLWNvbXByb21pc2VkLXRyYW5zZmVyLW9mLXNhcnMtY292LTItc3BlY2lmaWMtYW50aWJvZGllcy10aHJvdWdoLXBsYWNlbnRhL3ZpZGVvc2hvdy83OTk2NjkxNC5jbXPSAZoBaHR0cHM6Ly9tLnRpbWVzb2ZpbmRpYS5jb20vdmlkZW9zL25ld3MvcmVzZWFyY2gtcmV2ZWFscy1jb21wcm9taXNlZC10cmFuc2Zlci1vZi1zYXJzLWNvdi0yLXNwZWNpZmljLWFudGlib2RpZXMtdGhyb3VnaC1wbGFjZW50YS9hbXBfdmlkZW9zaG93Lzc5OTY2OTE0LmNtcw?oc=5
2020-12-26 23:30:00Z
52781261816712
Bagikan Berita Ini
0 Response to "Research reveals compromised transfer of SARS-CoV-2-specific antibodies through placenta - Times of India"
Post a Comment